Trial Profile
Evaluation of the Long-term Efficacy of the Injection of Botulinum Toxin A Into the Salivary Glands Versus Scopolamine Patches in the Treatment of Drooling in Children Over 4 Years Old With Cerebral Palsy.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary) ; Scopolamine
- Indications Cerebral palsy; Sialorrhoea
- Focus Therapeutic Use
- Acronyms TOXSIALO
- 27 Apr 2022 Planned End Date changed from 1 Jan 2025 to 1 Aug 2025.
- 27 Apr 2022 Planned primary completion date changed from 1 Jan 2025 to 1 Apr 2024.
- 27 Apr 2022 Status changed from not yet recruiting to recruiting.